Tag: RE-SPECT CVT
RE-SPECT trial establishes efficacy of Pradaxa for treatment of CVT patients
Boehringer Ingelheim has announced the publication of primary analysis from RE-SPECT CVT, the first exploratory, prospective, randomised controlled study of a NOAC in patients...